Literature DB >> 18080051

Prevalence of screening in patients newly diagnosed with colorectal cancer in Ontario.

C Taylor1, S E Schultz, L F Paszat, S Bondy, L Rabeneck.   

Abstract

OBJECTIVES: The primary objective was to determine the proportion of individuals with a new diagnosis of colorectal cancer (CRC) in Ontario in whom the cancer was screen detected. The secondary objectives were to determine the cancer stage at diagnosis and the indications for the procedure in patients who received their first colonoscopy. PATIENTS AND METHODS: Individuals admitted to a hospital with a new diagnosis of CRC were randomly selected after stratifying by hospital type (teaching or community). The Canadian Institute for Health Information's Discharge Abstract Database was used to identify individuals with a first diagnosis of CRC during calendar year (CY) 2000, and Ontario Health Insurance Plan data were used to identify people 50 to 74 years of age who had their first colonoscopy during CY 2000. Up to 20 individuals were selected for each group (CRC or colonoscopy) in each of seven randomly selected community hospitals and three randomly selected teaching hospitals. Data were abstracted from the hospital charts.
RESULTS: The hospital charts of 152 patients with a new diagnosis of CRC were examined. Of the 133 patients in whom screening status could be determined, eight had screen-detected cancers (6.0%). Of the 99 patients (65% of the sample) in whom stage could be determined, 43 (43.4%) had advanced disease (tumour-node-metastasis stage III or IV) at diagnosis. The hospital charts of 184 patients who underwent their first colonoscopy were examined. Of the 175 patients in whom the indication for colonoscopy could be determined, 45 underwent the procedure for screening purposes, 10 were for diagnostic workup of anemia and 120 for evaluation of symptoms.
CONCLUSIONS: The low proportion (6%) of screen-detected CRC and the high proportion of patients (43.4%) with advanced disease at diagnosis reflect the lack of an organized screening program.

Entities:  

Mesh:

Year:  2007        PMID: 18080051      PMCID: PMC2658572          DOI: 10.1155/2007/230420

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  11 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Receipt of colorectal testing prior to colorectal carcinoma diagnosis.

Authors:  Gregory S Cooper; Jonathan D Payes
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

3.  Utilization of colonoscopy in the United States: results from a national consortium.

Authors:  David A Lieberman; Jennifer Holub; Glenn Eisen; Dale Kraemer; Cynthia D Morris
Journal:  Gastrointest Endosc       Date:  2005-12       Impact factor: 9.427

4.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

Authors:  J S Mandel; T R Church; F Ederer; J H Bond
Journal:  J Natl Cancer Inst       Date:  1999-03-03       Impact factor: 13.506

5.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors:  B Towler; L Irwig; P Glasziou; J Kewenter; D Weller; C Silagy
Journal:  BMJ       Date:  1998-08-29

8.  Potential impact of population-based colorectal cancer screening in Canada.

Authors:  William M Flanagan; Christel Le Petit; Jean-Marie Berthelot; Kathleen J White; B Ann Coombs; Elaine Jones-McLean
Journal:  Chronic Dis Can       Date:  2003

9.  Patterns of use of flexible sigmoidoscopy, colonoscopy and gastroscopy: a population-based study in a Canadian province.

Authors:  Robert J Hilsden
Journal:  Can J Gastroenterol       Date:  2004-04       Impact factor: 3.522

10.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

View more
  1 in total

1.  Why so late?!--delay in treatment of colorectal cancer is socially determined.

Authors:  Mike Ralf Langenbach; Stefan Sauerland; Karl-Wilhelm Kröbel; Hubert Zirngibl
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.